Parliament Workbench
Data: Motions & questions to 19 Nov 2026 · Votes to 12 Nov 2026

Motion For Debate · S5M-12856 · Session 5

Access to Vital Medicines

Lodged by Anas Sarwar Lab Lodged 18 Jun 2018 Debate 20 Jun 2018

The motion

That the Parliament calls on the Scottish Government, as a matter of urgency, to bring NHS National Services Scotland, the Scottish Medicines Consortium and the relevant pharmaceutical companies together to deliver access to the life-prolonging medicines, Perjeta and Orkambi, for patients in Scotland who need them; notes the commitment that was made by the Scottish Government in December 2016, following the Review of Access to New Medicines (the Montgomery Review), to improve ways of negotiating with drug companies on the cost of medicines, and calls for a new system of negotiation to be implemented now.

What MSPs voted on: the motion as amended

Labour’s motion was rewritten by amendments from the SNP (S5M-12856.3) and the Conservatives (S5M-12856.1) before this vote. A vote ‘for’ was a vote for the motion as amended, not as lodged.

That the Parliament calls on the Scottish Government, as a matter of urgency, to bring NHS National Services Scotland, the Scottish Medicines Consortium and the relevant pharmaceutical companies together to deliver access to the life-prolonging medicines, Perjeta and Orkambi, for patients in Scotland who need them; notes the commitment that was made by the Scottish Government in December 2016, following the Review of Access to New Medicines (the Montgomery Review), to improve ways of negotiating with drug companies on the cost of medicines, and calls for a new system of negotiation to be implemented now.S5M-12856.3 SNP ; welcomes the introduction of a new ultra-orphan pathway within the Scottish Medicines Consortium process that will make available, with ongoing evaluation for at least three years, medicines for the rarest conditions; notes the roll-out of the Peer Approved Clinical System in June 2018, replacing individual patient treatment requests, which allows clinicians to seek medicines for their patients that are not currently accepted for routine use by the NHS in Scotland, and which makes clear that the cost of the medicine must not be part of the decision-making process; further notes the commitment of the Scottish Government to continue to use all Pharmaceutical Price Regulation Scheme rebate funding to support access to new medicines; welcomes the commitment of the Association of the British Pharmaceutical Industry for its members to provide Scotland with the same discounts offered elsewhere in the UK for accessing medicines, and believes that pharmaceutical companies should offer NHS Scotland fair prices and should properly engage with health technology assessments in order to demonstrate the clinical effectiveness of their medicines.S5M-12856.1 Conservative , and further calls on the Scottish Government to remove barriers to make access to new drugs easier, including the reform of the Patient Access Scheme Assessment Group.

Final wording as read into the Official Report at Decision Time. The marked changes are worked out by this site from the amendment texts and match that wording.

Amendments

  1. S5M-12856.2 Green Alison Johnstone Not put to a vote (worked out by this site: never called at Decision Time: not selected or not moved)
  2. S5M-12856.3 SNP Shona Robison Agreed without a vote, per the Official Report
  3. S5M-12856.1 Conservative Miles Briggs Agreed without a vote, per the Official Report

Vote

No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.

Amendments

3
  1. Access to Vital Medicines
    Miles Briggs Con Lodged 19 Jun 2018
    No recorded vote
  2. Access to Vital Medicines
    Alison Johnstone Green Lodged 19 Jun 2018
    No recorded vote
  3. Access to Vital Medicines
    Shona Robison SNP Lodged 19 Jun 2018
    No recorded vote

Supporters

No MSP has added their name to this motion.

In the Official Report

4 contributions mention S5M-12856
  1. 20 Jun 2018
    Access to Medicines
    Linda Fabiani SNP Meeting of the Parliament

    The next item of business is a debate on motion S5M-12856, in the name of Anas Sarwar, on access to vital medicines. We are a bit behind time already for this debate, so I ask members to bear that in mind. 15:51

  2. 20 Jun 2018
    Decision Time
    Ken Macintosh Meeting of the Parliament

    The next question is, that amendment S5M-12856.3, in the name of Shona Robison, which seeks to amend motion S5M-12856, in the name of Anas Sarwar, on access to vital medicines, be agreed to. Amendment agreed to.

  3. 20 Jun 2018
    Decision Time
    Ken Macintosh Meeting of the Parliament

    The next question is, that amendment S5M-12856.1, in the name of Miles Briggs, which seeks to amend motion S5M-12856, as amended, be agreed to. Amendment agreed to.

  4. 20 Jun 2018
    Decision Time
    Ken Macintosh Meeting of the Parliament

    The next question is, that motion S5M-12856, in the name of Anas Sarwar, on access to vital medicines, as amended, be agreed to. Motion, as amended, agreed to, That the Parliament calls on the Scottish Government, as a matter of urgency, t…